2013
DOI: 10.5863/1551-6776-18.2.137
|View full text |Cite
|
Sign up to set email alerts
|

Stenotrophomonas Infection in a Patient with Glucose-6-Phosphate Dehydrogenase Deficiency

Abstract: The drug of choice for treatment of Stenotrophomonas maltophilia is sulfamethoxazole/trimethoprim, and second-line therapy usually consists of a fluoroquinolone. However, in patients with glucose-6-phosphate dehydrogenase deficiency, neither sulfamethoxazole/trimethoprim nor a fluoroquinolone is a preferred option as it may result in hemolysis. Currently, there is a paucity of data regarding treatment of S maltophilia infection in these patients. This case report presents a patient who was successfully treated… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2014
2014
2022
2022

Publication Types

Select...
3
2

Relationship

0
5

Authors

Journals

citations
Cited by 5 publications
(2 citation statements)
references
References 15 publications
0
2
0
Order By: Relevance
“…For the treatment of S. maltophilia infection, trimethoprim-sulfamethoxazole is still considered as the first-line therapeutic agent of choice, but resistance (2%-25%) has also been reported as an increasing problem for this pathogen [16][17][18]. Alternative agents include piperacillin, fluoroquinolones (e.g., levofloxacin and moxifloxacin), and tetracycline derivatives (e.g., minocycline) [19].…”
Section: Discussionmentioning
confidence: 99%
“…For the treatment of S. maltophilia infection, trimethoprim-sulfamethoxazole is still considered as the first-line therapeutic agent of choice, but resistance (2%-25%) has also been reported as an increasing problem for this pathogen [16][17][18]. Alternative agents include piperacillin, fluoroquinolones (e.g., levofloxacin and moxifloxacin), and tetracycline derivatives (e.g., minocycline) [19].…”
Section: Discussionmentioning
confidence: 99%
“…A plethora of bacterial and fungal infections was identified in several studies that described the infections in G6PD-deficient patients, among which pneumonia, gastrointestinal, osteomyelitis, cerebrospinal, and septicemia were more common. Most of these infections were caused by Chromobacterium violaceum [ 10 ], Staphylococcus aureus [ 11 ], Escherichia coli [ 12 ], Serratia marcescens [ 13 ], Acinetobacter baumannii [ 14 ], Klebsiella pneumoniae [ 15 ], Pseudomonas aeruginosa [ 16 ], Salmonella species , Staphylococcus epidermidis , Clostridium difficile [ 17 ], and Aspergillus species [ 6 ].…”
Section: Introductionmentioning
confidence: 99%